全文获取类型
收费全文 | 1859篇 |
免费 | 262篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 68篇 |
妇产科学 | 29篇 |
基础医学 | 104篇 |
口腔科学 | 94篇 |
临床医学 | 297篇 |
内科学 | 475篇 |
皮肤病学 | 40篇 |
神经病学 | 64篇 |
特种医学 | 299篇 |
外科学 | 175篇 |
综合类 | 22篇 |
预防医学 | 300篇 |
眼科学 | 12篇 |
药学 | 42篇 |
肿瘤学 | 112篇 |
出版年
2023年 | 48篇 |
2022年 | 14篇 |
2021年 | 15篇 |
2020年 | 41篇 |
2019年 | 22篇 |
2018年 | 56篇 |
2017年 | 35篇 |
2016年 | 45篇 |
2015年 | 55篇 |
2014年 | 99篇 |
2013年 | 124篇 |
2012年 | 53篇 |
2011年 | 63篇 |
2010年 | 73篇 |
2009年 | 88篇 |
2008年 | 61篇 |
2007年 | 85篇 |
2006年 | 59篇 |
2005年 | 51篇 |
2004年 | 48篇 |
2003年 | 31篇 |
2002年 | 26篇 |
2001年 | 26篇 |
2000年 | 28篇 |
1999年 | 35篇 |
1998年 | 69篇 |
1997年 | 89篇 |
1996年 | 82篇 |
1995年 | 62篇 |
1994年 | 63篇 |
1993年 | 53篇 |
1992年 | 22篇 |
1991年 | 16篇 |
1990年 | 32篇 |
1989年 | 45篇 |
1988年 | 34篇 |
1987年 | 36篇 |
1986年 | 35篇 |
1985年 | 36篇 |
1984年 | 16篇 |
1983年 | 13篇 |
1982年 | 24篇 |
1981年 | 33篇 |
1980年 | 20篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1977年 | 17篇 |
1976年 | 15篇 |
1975年 | 11篇 |
1968年 | 3篇 |
排序方式: 共有2142条查询结果,搜索用时 0 毫秒
41.
Kahli Zietlow MD Leslie Dubin MSW Alethia Battles JD MSW Caroline Vitale MD 《Journal of the American Geriatrics Society》2022,70(11):3070-3079
Guardianship may pose an ethical dilemma for physicians, who must balance protecting vulnerable patients from potential safety concerns with respecting their autonomy. Older adults with dementia are particularly susceptible to loss of independence and the ability to participate in medical decision making. To have the capacity for medical decision making, individuals must understand relevant information, appreciate their circumstances, demonstrate reasoning, and express a consistent choice free from coercion. Although capacity assessments are usually task-specific, geriatricians and other specialists may be asked to comment on capacity more globally. These determinations may be used to support a Petition for the Appointment of a Guardian of a Legally Incapacitated Adult, the legal process of pursuing guardianship in probate court. Assigned guardians may be known to the incapacitated individual (e.g., a family member or friend) or may be professional guardians with no prior relationship to the ward. Guardians are encouraged to use substituted decision-making, taking into account the ward's previously expressed values and preferences. Although a number of viable alternatives to guardianship exist, numerous systemic barriers may prevent these from being fully explored. The ongoing need for guardianship should be periodically revisited and reassessed. Data about guardians and wards is shockingly sparse, as there are no centralized databases. Laws and regulations for guardianships vary significantly between states. Physicians can serve as important allies and advocates for patients with cognitive impairment at risk of incapacity, can help preserve their autonomy for as long as possible, and ensure appropriate protections are in place if the patient does lose their decision-making ability. 相似文献
42.
43.
44.
45.
46.
47.
48.
JD Roberts JC Herkert J Rutberg SM Nikkel ACP Wiesfeld D Dooijes RM Gow JP van Tintelen MH Gollob 《Clinical genetics》2013,83(5):452-456
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited myocardial disease that predominantly affects the right ventricle and is associated with ventricular arrhythmias that may lead to sudden cardiac death. Mutations within at least seven separate genes have been identified to cause ARVC, however a genetic culprit remains elusive in approximately 50% of cases. Although negative genetic testing may be secondary to pathogenic mutations within undiscovered genes, an alternative explanation may be the presence of large deletions or duplications involving known genes. These large copy number variants may not be detected with standard clinical genetic testing which is presently limited to direct DNA sequencing. We describe two cases of ARVC possessing large deletions involving plakophilin‐2 (PKP2) identified with microarray analysis and/or multiplex ligation‐dependent probe amplification (MLPA) that would have been classified as genotype negative with standard clinical genetic testing. A deletion of the entire coding region of PKP2 excluding exon 1 was identified in patient 1 and his son. In patient 2, MLPA analysis of PKP2 revealed deletion of the entire gene with subsequent microarray analysis demonstrating a de novo 7.9 Mb deletion of chromosome 12p12.1p11.1. These findings support screening for large copy number variants in clinically suspected ARVC cases without clear disease causing mutations following initial sequencing analysis. 相似文献
49.
Stephanie R McKeown Paul Hatfield Robin JD Prestwich Richard E Shaffer Roger E Taylor 《The British journal of radiology》2015,88(1056)
Most radiotherapy (RT) involves the use of high doses (>50 Gy) to treat malignant disease. However, low to intermediate doses (approximately 3–50 Gy) can provide effective control of a number of benign conditions, ranging from inflammatory/proliferative disorders (e.g. Dupuytren''s disease, heterotopic ossification, keloid scarring, pigmented villonodular synovitis) to benign tumours (e.g. glomus tumours or juvenile nasopharyngeal angiofibromas). Current use in UK RT departments is very variable. This review identifies those benign diseases for which RT provides good control of symptoms with, for the most part, minimal side effects. However, exposure to radiation has the potential to cause a radiation-induced cancer (RIC) many years after treatment. The evidence for the magnitude of this risk comes from many disparate sources and is constrained by the small number of long-term studies in relevant clinical cohorts. This review considers the types of evidence available, i.e. theoretical models, phantom studies, epidemiological studies, long-term follow-up of cancer patients and those treated for benign disease, although many of the latter data pertain to treatments that are no longer used. Informative studies are summarized and considered in relation to the potential for development of a RIC in a range of key tissues (skin, brain etc.). Overall, the evidence suggests that the risks of cancer following RT for benign disease for currently advised protocols are small, especially in older patients. However, the balance of risk vs benefit needs to be considered in younger adults and especially if RT is being considered in adolescents or children. 相似文献
50.
Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe
下载免费PDF全文
![点击此处可从《HIV medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
JR Santos A Cozzi‐Lepri A Phillips S De Wit C Pedersen P Reiss A Blaxhult A Lazzarin M Sluzhynska C Orkin C Duvivier J Bogner P Gargalianos‐Kakolyris P Schmid G Hassoun I Khromova M Beniowski V Hadziosmanovic D Sedlacek R Paredes JD Lundgren 《HIV medicine》2018,19(5):324-338